0 Comentários
0 Compartilhamentos
3KB Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Non-Genetically Modified Organisms (GMO) Testing Market Overview, Growth Analysis, Trends and Forecast By 2029"Competitive Analysis of Executive Summary Non-Genetically Modified Organisms (GMO) Testing Market Size and Share Data Bridge Market Research analyses that the non-genetically modified organisms (GMO) testing market was valued at USD 2.26 billion in 2021 and is expected to reach the value of USD 4.67 billion by 2029, at a CAGR of 9.50% during the forecast period. A competition that is getting...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Non-Genetically Modified Organisms (GMO) Testing Market Overview, Growth Analysis, Trends and Forecast By 2029"Executive Summary Non-Genetically Modified Organisms (GMO) Testing Market : Data Bridge Market Research analyses that the non-genetically modified organisms (GMO) testing market was valued at USD 2.26 billion in 2021 and is expected to reach the value of USD 4.67 billion by 2029, at a CAGR of 9.50% during the forecast period. In this Non-Genetically Modified Organisms (GMO) Testing...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Non-GMO Testing Market: Ensuring Food Transparency and SafetyExecutive Summary Non-Genetically Modified Organisms (GMO) Testing Market Size and Share Analysis Report CAGR Value Data Bridge Market Research analyses that the non-genetically modified organisms (GMO) testing market was valued at USD 2.26 billion in 2021 and is expected to reach the value of USD 4.67 billion by 2029, at a CAGR of 9.50% during the forecast period. This...0 Comentários 0 Compartilhamentos 540 Visualizações 0 Anterior
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations in the...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Why Is North America Leading Innovation in CTC Liquid Biopsy Technologies?"Executive Summary North America Circulating Tumor Cells (CTC) Liquid Biopsy Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the market is growing with a CAGR of 25.9% in the forecast period of 2022 to 2029 and is expected to reach USD 2,650.96 million by 2029 from USD 442.64 million in 2021. The key topics that have been described in this...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek